Yunjian Zhang

58# Zhongshan Two Road
Guangzhou, 510080, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 37 publications

Contrast-Enhanced Ultrasound Combined with Methylene Blue for Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Patients with Initially cN1 Breast Cancer: A Multicenter Prospective Cohort Study.

Contrast-Enhanced Ultrasound Combined with Methylene Blue for Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Patients with Initially cN1 Breast Cancer: A Multicenter Prospective Cohort Study.

Journal: Cancers

Published: June 12, 2026

Wnt/β-Catenin-mTOR-autophagy crosstalk in breast cancer: context-dependent control of tumor progression, immune suppression, and therapeutic resistance.

Wnt/β-Catenin-mTOR-autophagy crosstalk in breast cancer: context-dependent control of tumor progression, immune suppression, and therapeutic resistance.

Journal: Frontiers in immunology

Published: March 30, 2026

Soluble HER2 promotes chronic antigen-mediated CD8⁺ T-cell dysfunction and limits immunotherapy response in HER2-low triple-negative breast cancer.

Soluble HER2 promotes chronic antigen-mediated CD8⁺ T-cell dysfunction and limits immunotherapy response in HER2-low triple-negative breast cancer.

Journal: Cell death & disease

Published: March 22, 2026

Neoadjuvant Taxane Plus Trastuzumab and Pertuzumab With or Without Carboplatin in Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: The Randomized Noninferiority Phase III neoCARHP Trial.

Neoadjuvant Taxane Plus Trastuzumab and Pertuzumab With or Without Carboplatin in Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: The Randomized Noninferiority Phase III neoCARHP Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: January 23, 2026

Circulating tumor DNA in breast cancer: From technological foundation to clinical implementation.

Circulating tumor DNA in breast cancer: From technological foundation to clinical implementation.

Journal: Cancer treatment reviews

Published: December 30, 2025

Integrative cfDNA profiling from low-pass whole-genome sequencing enables tissue-of-origin prediction in cancer.

Integrative cfDNA profiling from low-pass whole-genome sequencing enables tissue-of-origin prediction in cancer.

Journal: Molecular biomedicine

Published: October 24, 2025

Immunotherapy and Breast Reconstruction: Opportunities, Challenges, and Future Directions.

Immunotherapy and Breast Reconstruction: Opportunities, Challenges, and Future Directions.

Journal: Cancer medicine

Published: October 22, 2025

Tumor-derived PCSK9-enriched exosomes reprogram adipocytes to drive metabolic dysregulation and immune evasion in triple-negative breast cancer.

Tumor-derived PCSK9-enriched exosomes reprogram adipocytes to drive metabolic dysregulation and immune evasion in triple-negative breast cancer.

Journal: Cell death & disease

Published: September 11, 2025

Prognosis and endocrine therapy efficacy in early breast cancer with estrogen receptor low expression.

Prognosis and endocrine therapy efficacy in early breast cancer with estrogen receptor low expression.

Journal: Breast cancer research and treatment

Published: September 08, 2025

Investigating the shared genetic architecture and causality of breast cancer and thyroid cancer: genome-wide cross trait analysis and bi-directional Mendelian randomization study.

Investigating the shared genetic architecture and causality of breast cancer and thyroid cancer: genome-wide cross trait analysis and bi-directional Mendelian randomization study.

Journal: Breast cancer (Tokyo, Japan)

Published: August 26, 2025

Association of patient health education with the postoperative health related quality of life in low- intermediate recurrence risk differentiated thyroid cancer patients.

Association of patient health education with the postoperative health related quality of life in low- intermediate recurrence risk differentiated thyroid cancer patients.

Journal: Scientific reports

Published: February 28, 2025

Patterns of Recurrence and Survival Outcomes of HER2-Low Expression in Early-Stage Breast Cancer.

Patterns of Recurrence and Survival Outcomes of HER2-Low Expression in Early-Stage Breast Cancer.

Journal: Clinical breast cancer

Published: April 25, 2024

Showing 1-12 of 37

Last Updated: 09/26/2026